EZElisa™人分化抗原34（CD34）ELISA试剂盒-
EZElisa™ Human Cluster Of Differentiation 34 (CD34) ELISA Kit- 询价
- Biogradetech
- 美国
- A-QEK00190-96wells
- 2025年08月28日
企业认证
相关产品推荐更多 >
EZElisa™小鼠非活性羧肽酶样蛋白X2（CPXM2）ELISA试剂盒-EZElisa™ Mouse Inactive carboxypeptidase Like Protein X2 (CPXM2) ELISA Kit
询价
Hamster Cytidine Deaminase ELISA Kit/Hamster Cytidine Deaminase ELISA Kit
询价
EZElisa™人磷酸甘油酸突变酶2（PGAM2）ELISA试剂盒-EZElisa™ Human Phosphoglycerate Mutase 2 (PGAM2) ELISA Kit
询价Cat Neuroglobin ELISA Kit/Cat Neuroglobin ELISA Kit
询价
Canine P62 Antibody ELISA Kit/Canine P62 Antibody ELISA Kit
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
运输过程中保存：2-8℃
- 保质期：
1年
- 英文名：
EZElisa™ Human Cluster Of Differentiation 34 (CD34) ELISA Kit
- 库存：
100
- 供应商：
艾美捷科技
EZElisa™人分化抗原34（CD34）ELISA试剂盒，EZElisa™ Human Cluster Of Differentiation 34 (CD34) ELISA Kit，分化抗原34（CD34）ELISA试剂盒, Cluster Of Differentiation 34 (CD34) ELISA Kit
产品名称：EZElisa™ 人 CMRF35-Like Molecule 7（CD300LB）ELISA试剂盒-EZElisa™ Human Cluster Of Differentiation 34 (CD34) ELISA Kit
产品货号：A-QEK00190-96wells
产品规格：96wells
Enzyme Immunoassay for the estimation of Human Cluster Of Differentiation 34 (CD34) in serum and plasma, tissue homogenates and other biological fluids.
种属：Human
检测方法：比色法
检测范围：0.312 - 20 ng/ml
该EZElisa™人分化抗原34（CD34）ELISA试剂盒ELISA的特点包括：即用即用的操作步骤标准化和高重复性批次之间的一致性准确性和精确性经过七个点的验证，符合金环标准质量ELISA的要求，这是Biogradetech质量的基准标志。EZElisa™ ELISA试剂盒用于评估样品中的特定生物标志物，样品可以是血清
运输过程中保存：2-8℃
点击：EZElisa™ 人 CMRF35-Like Molecule 7（CD300LB）ELISA试剂盒-EZElisa™ Human Cluster Of Differentiation 34 (CD34) ELISA Kit更多Biogradetech产品信息价格，货期，产品说明，百度搜“艾美捷科技”进入官网网站，查看具体产品且快速下单。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Antigen-presenting dendritic cells (DCs) originate from hematopoietic stem cells in bone marrow through successive steps of differentiation (1 -5 ). In peripheral tissues (e.g., skin), DCs are exposed to and capture antigens like viruses
of multipotent CD34+ CD45+ hematopoietic progenitors via employing hEB hematopoietic differentiation followed by adherent hemogenic endothelium generation. Multipotent hematopoietic progenitors can be reproducibly generated in robust amounts
and biochemical link between self-renewal and differentiation can now be experimentally approached using primary human cells. In addition, the models that result from these experiments are likely to generate highly relevant systems for use in identification
技术资料暂无技术资料 索取技术资料
